Dr. Quinn is NIH and VA-funded to conduct translational research in neurodegenerative disease, including work with animal models, biomarkers, and clinical trials. His research focus is on cognitive decline in Parkinson’s disease and other neurodegenerative diseases. Dr.Quinn’s research interests include assessing biomarkers in Alzheimer’s disease, developing improved model systems for screening potential treatments for Alzheimer’s disease, and testing new compounds that target Alzheimer’s disease.